Omalizumab in severe allergic asthma

10th May 2013 by Louise Hudman

This guideline advises that Omalizumab can be used in the treatment of asthma. It is a monoclonal antibody that binds to IgE and is given every 2 to 4 weeks subcut. We may start seeing patients treated with this, so worth knowing about it. Treatment is to be started and maintained by specialists only. Quite a lot of criteria must be met before use, so it’ll only be used in the most severe asthma, where allergy testing has been positive.

Join

Join to view the rest of this content, as well as access all the benefits of joining NASGP.

Join

Login

Already a member? Login to view this content.

Login

"We’ve worked with the NASGP now for over a decade, and have always been impressed with their commitment to promoting a really productive working relationship between practices and GP locums, with the ultimate aim of making sure patients receive the best care, no matter which GP they see."

Lynda Cox, Practice Cover

Lynda Cox, Practice Cover

See the full list of features within our NASGP membership plans

Membership